meeting news
Real-World Data Show Continued Virologic Suppression With Cabenuva
At CROI 2025, new research has shown high rates of continued virologic suppression with cabotegravir-rilpivirine ...
MARCH 25, 2025
Ensitrelvir Reduced the Risk for COVID-19 by 67%
Ensitrelvir, an antiretroviral being developed to prevent COVID-19, reduced the risk of developing the infection by ...
MARCH 13, 2025
Load more